Ad
related to: florbetapir f 18 injection- Sign Up for Updates
Sign up to receive the latest data,
case studies, and resources.
- Case Studies
Review real case studies
with real patients.
- Find an Imaging Site
Locate the nearest imaging site
or contact customer service.
- Contact Us
Contact our representatives
for product and reimbursement info.
- Sign Up for Updates
Search results
Results from the WOW.Com Content Network
Florbetapir (18 F), sold under the brand name Amyvid, is a PET scanning radiopharmaceutical compound containing the radionuclide fluorine-18 that was approved for use in the United States in 2012, [4] as a diagnostic tool for Alzheimer's disease.
Florbetaben, sold under the brand name Neuraceq, is a diagnostic radiotracer developed for routine clinical application to visualize β-amyloid plaques in the brain. It is a fluorine-18 (18 F)-labeled stilbene derivative.
Flortaucipir (18 F), sold under the brand name Tauvid, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) imaging to image the brain. [ 1 ] [ 3 ] [ 4 ] The most common adverse reactions include headache, injection site pain and increased blood pressure.
Flurpiridaz F-18 is a fluorine 18-labeled agent developed by Lantheus Medical Imaging for the diagnosis of coronary artery disease. [6]The efficacy and safety of flurpiridaz (18 F) were evaluated in two prospective, multicenter, open-label clinical studies in adults with either suspected CAD (Study 1: NCT03354273) or known or suspected CAD (Study 2: NCT01347710). [3]
WASHINGTON (Reuters) -A massive winter storm moving across the United States will not keep the U.S. Congress from meeting on Monday to formally certify Republican Donald Trump's election as ...
“You have to [try],” Mahomes said on Tuesday. “That’s the reason you play this game, to push to play. I’m not going to put our team in a bad position.
Flutemetamol (18 F) (trade name Vizamyl, by GE Healthcare) is a PET scanning radiopharmaceutical containing the radionuclide fluorine-18, used as a diagnostic tool for Alzheimer's disease. [ 2 ] Adverse effects
The Consumer Financial Protection Bureau (CFPB) on Wednesday warned that credit card companies devaluing or canceling reward points, cash back or miles rewards programs may be breaking the law.
Ad
related to: florbetapir f 18 injection